GNS Healthcare | GenomeWeb

GNS Healthcare

Most recently, Celgene has licensed the GNS platform for internal use and made an undisclosed equity investment in the company.

The firm will use the funding, which comes from both new and existing investors, to develop new cloud-based solutions for precision medicine.

GNS Healthcare and the Multiple Myeloma Research Foundation to use GNS' informatics solutions to explore genomic and clinical data from the CoMMpass study.

Robert Hoyt has joined GenomeQuest's board of directors
Hoyt is currently Eximo's chief operating officer. Prior to that, he was the general manager of Endeca Technologies which sold to Oracle in 2011.

Knome has hired Josh Forsythe as its new vice president of sales and marketing. He joins the company after 10 years at Golden Helix, where held several positions including VP of business development, VP of sales and marketing, and director of marketing.

Increasing investments from venture capital firms in commercial bioinformatics indicates that the perceived value of the market is rising and suggests a level of optimism about the revenue potential of a segment of the life sciences space that historically hasn't been seen as par

GNS Healthcare will use a portion of the proceeds from a recently wrapped $10 million funding round to add support for new types of data to its proprietary analytics platform and to reengineer the system’s software and code so that its analysis is more automated, according to a c

NEW YORK (GenomeWeb News) — GNS Healthcare has reeled in $10 million in financing that it will use to expand its data analytic business more broadly across the healthcare industry.

NEW YORK (GenomeWeb News) – The Inova Translational Medicine Institute and GNS Healthcare today announced a deal to develop and commercialize computer models based on GNS' technology.

NEW YORK (GenomeWeb News) – Big data analysis firm GNS Healthcare announced today that Harvard Medical School is licensing its REFS analytics platform for the characterization and elucidation of signaling and transcriptional events in biological systems.

Pages

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.